InsiderTrades.com logo

Les Korsh Biography and Net Worth

VP of iTeos Therapeutics
  • Phone
  • Email
  • Website


Les Korsh is the VP of iTeos Therapeutics.

What is Les B. Korsh's net worth?

The estimated net worth of Les B. Korsh is at least $1.05 million as of July 3rd, 2024. Korsh owns 103,765 shares of iTeos Therapeutics stock worth more than $1,053,215 as of December 5th. This net worth approximation does not reflect any other assets that Korsh may own. Learn More about Les B. Korsh's net worth.

How do I contact Les B. Korsh?

The corporate mailing address for Korsh and other iTeos Therapeutics executives is , , . iTeos Therapeutics can also be reached via phone at 339-217-0161 and via email at [email protected]. Learn More on Les B. Korsh's contact information.

Has Les B. Korsh been buying or selling shares of iTeos Therapeutics?

Les B. Korsh has not been actively trading shares of iTeos Therapeutics in the last ninety days. Learn More on Les B. Korsh's trading history.

Who are iTeos Therapeutics' active insiders?

iTeos Therapeutics' insider roster includes Detlev Biniszkiewicz (Director), Michel Detheux (CEO), Ansbert Gadicke (Major Shareholder), Matthew Gall (CFO), David Hallal (Director), Les Korsh (VP), Joanne Lager (Insider), and Yvonne McGrath (VP). Learn More on iTeos Therapeutics' active insiders.

Are insiders buying or selling shares of iTeos Therapeutics?

During the last year, insiders at the sold shares 11 times. They sold a total of 1,939,307 shares worth more than $16,202,115.73. The most recent insider tranaction occured on June, 10th when CEO Michel Detheux sold 43,883 shares worth more than $439,707.66. Insiders at iTeos Therapeutics own 14.2% of the company. Learn More about insider trades at iTeos Therapeutics.

Information on this page was last updated on 6/10/2025.

Les B. Korsh Insider Trading History at iTeos Therapeutics

See Full Table

Les B. Korsh Buying and Selling Activity at iTeos Therapeutics

This chart shows Les B Korsh's buying and selling at iTeos Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

iTeos Therapeutics Company Overview

iTeos Therapeutics logo
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Read More

Today's Range

Now: $10.15
Low: $10.15
High: $10.15

50 Day Range

MA: $10.14
Low: $10.09
High: $10.23

2 Week Range

Now: $10.15
Low: $4.80
High: $17.63

Volume

N/A

Average Volume

1,505,580 shs

Market Capitalization

$448.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31